Opportunity Information: Apply for PAR 07 294

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Preliminary Investigations Leading To Optimal Trials In Neurology (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
  • This funding opportunity was created on Dec 5, 2008 and posted on Jan 11, 2007.
  • Applicants must submit their applications by Jan 7, 2010 Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Public and State controlled institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments For profit organizations other than small businesses Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Private institutions of higher education.
  • Foreign institutions are eligible to apply.
Apply for PAR 07 294

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "Preliminary Investigations Leading To Optimal Trials In Neurology (R01)" (Funding Opportunity Number PAR 07-294) is a National Institutes of Health (NIH) program, associated with CFDA 93.853, that supports early-stage clinical research aimed at setting up a strong, evidence-based foundation for later, definitive clinical trials in neurology. Run through the National Institute of Neurological Disorders and Stroke (NINDS) under NIH Extramural Research Programs in the neurosciences and neurological disorders, the central goal is not to fund a large, confirmatory trial right away, but to generate the kind of preliminary human data and practical trial-enabling information that makes a future full-scale clinical trial scientifically justified and operationally feasible.

The purpose of this funding announcement is narrowly focused on "preliminary investigations" that directly strengthen the rationale for a subsequent definitive clinical trial of an intervention intended to treat or prevent neurological disease. In practice, this means applicants are expected to propose studies that reduce uncertainty and risk before a larger trial is launched. Typical work supported under this kind of objective can include gathering preliminary signals about safety and tolerability, estimating effect sizes to support power calculations, refining inclusion and exclusion criteria, validating or selecting clinical endpoints and outcome measures, confirming feasibility of recruitment and retention strategies, testing dosing or delivery approaches, and establishing whether the intervention and trial procedures can be implemented consistently across sites. The emphasis is on producing actionable data that will improve the design and likelihood of success of a later pivotal trial, rather than simply collecting general exploratory data without a clear line of sight to trial readiness.

The mechanism of support is the NIH Research Project Grant (R01). Using the R01 mechanism generally signals that the program expects a well-developed research plan with rigorous methods, a qualified investigative team, and a budget and project period appropriate to the proposed scope. At the same time, because the announcement is built around preliminary, trial-optimizing work, the supported projects can vary widely in size and duration depending on what specific evidence gaps need to be addressed to justify and properly design the subsequent definitive clinical trial.

Funding levels and the number of awards are not fixed. The announcement states that awards are contingent on the availability of funds and on receiving a sufficient number of meritorious applications. It also notes that because applications may differ significantly in scientific scope and logistical complexity, both the award size and the project duration are expected to vary from one funded project to another. In other words, there is no single standard budget cap or standardized project length described in the summary; funding decisions will depend on the proposed approach, time needed, cost structure, and overall scientific merit.

In terms of eligibility, the opportunity is broadly open across many organizational types. Eligible applicants include a wide range of U.S. governmental entities (such as state governments, county governments, city or township governments, special district governments, and independent school districts), public and state-controlled institutions of higher education, private institutions of higher education, public housing authorities/Indian housing authorities, and multiple categories of nonprofit and for-profit organizations. Notably, the eligibility list includes nonprofits with and without 501(c)(3) status (with the exception language specified in the listing), for-profit organizations other than small businesses, and small businesses. The program also explicitly includes Native American tribal governments (federally recognized) and Native American tribal organizations (other than federally recognized tribal governments). A key point in the eligibility information is that foreign institutions are eligible to apply, which can be important for multinational or non-U.S.-based research groups seeking to conduct early clinical investigations relevant to neurological disorders.

Administratively, the opportunity is categorized as discretionary and uses the grant funding instrument type, with a health-related funding activity category. The posting date is listed as January 11, 2007, with a creation date of December 5, 2008. The announcement operated with multiple receipt dates, and the provided record shows a current closing date of January 7, 2010, with an archive date of February 7, 2010. Applicants were directed to the full announcement for the specific receipt dates and detailed requirements via the NIH grants guide link (http://grants.nih.gov/grants/guide/pa-files/PAR-07-294.html). For access or linking issues, the contact provided is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Overall, this FOA is best understood as a bridge between preclinical or early clinical concepts and a later, definitive neurology trial: it funds the critical preparatory clinical work that clarifies whether an intervention is ready for a major trial and, just as importantly, determines how that trial should be designed to yield clear, reliable, and clinically meaningful results.

Frequently Asked Questions (FAQs): Preliminary Investigations Leading To Optimal Trials In Neurology (R01) (PAR-07-294)

What is the title and funding opportunity number for this grant?

The opportunity is titled "Preliminary Investigations Leading To Optimal Trials In Neurology (R01)" and the Funding Opportunity Number is PAR 07-294.

Which agency and institute run this opportunity?

This is a National Institutes of Health (NIH) program run through the National Institute of Neurological Disorders and Stroke (NINDS) under NIH Extramural Research Programs focused on the neurosciences and neurological disorders.

What is the CFDA number associated with this opportunity?

The opportunity is associated with CFDA 93.853.

What is the main purpose of this funding opportunity?

The purpose is to support early-stage clinical research that produces trial-enabling evidence and practical information needed to justify and properly design a later, definitive clinical trial in neurology. The central goal is to strengthen the evidence-based foundation for a subsequent full-scale trial rather than to fund a large confirmatory trial immediately.

Is this intended to fund a definitive, large-scale confirmatory clinical trial?

No. The focus is narrowly on "preliminary investigations" that reduce uncertainty and risk before launching a larger, definitive (pivotal) clinical trial.

What kinds of studies fit the "preliminary investigations" focus described here?

Studies are expected to directly strengthen the rationale for a later definitive trial and improve trial readiness. Examples described include work to gather preliminary human data and trial-optimizing information such as safety/tolerability signals, effect size estimates for power calculations, refining inclusion/exclusion criteria, selecting or validating endpoints/outcomes, assessing recruitment and retention feasibility, testing dosing or delivery approaches, and confirming that procedures can be implemented consistently across sites.

What kinds of outcomes or deliverables are emphasized?

The emphasis is on actionable, trial-enabling data that improves the design and likelihood of success of a later pivotal trial. The supported work should have a clear line of sight to trial readiness rather than being purely exploratory without a direct connection to enabling a subsequent definitive trial.

What grant mechanism is used?

The mechanism of support is the NIH Research Project Grant (R01).

What does using the R01 mechanism imply about the application?

Using an R01 generally signals an expectation for a well-developed research plan with rigorous methods, a qualified investigative team, and a budget and project period appropriate to the proposed scope.

Are the award amounts and project durations fixed?

No. Funding levels and the number of awards are not fixed. Awards are contingent on the availability of funds and on receiving a sufficient number of meritorious applications. Because applications may vary in scientific scope and logistical complexity, both award size and project duration are expected to vary across funded projects.

How is the number of awards determined?

The announcement indicates awards depend on the availability of funds and the receipt of a sufficient number of meritorious applications.

What type of funding instrument is used?

The opportunity uses the grant funding instrument type.

How is this opportunity categorized administratively?

It is categorized as discretionary and falls under a health-related funding activity category.

Who is eligible to apply?

Eligibility is broad and includes many organizational types, such as U.S. governmental entities (state, county, city or township governments, special district governments, and independent school districts), public and state-controlled institutions of higher education, private institutions of higher education, public housing authorities/Indian housing authorities, and multiple categories of nonprofit and for-profit organizations.

Are nonprofit organizations eligible?

Yes. The eligibility list includes nonprofits with and without 501(c)(3) status (with exception language referenced in the listing).

Are for-profit organizations eligible?

Yes. The eligibility list includes for-profit organizations other than small businesses, and it also includes small businesses.

Are tribal entities eligible?

Yes. The eligibility list explicitly includes Native American tribal governments (federally recognized) and Native American tribal organizations (other than federally recognized tribal governments).

Are foreign institutions eligible to apply?

Yes. A key point in the eligibility information is that foreign institutions are eligible to apply.

What diseases or field does this opportunity focus on?

The program is focused on neurology, specifically early-stage clinical research intended to support later definitive clinical trials of interventions to treat or prevent neurological disease.

What is the relationship between this program and later clinical trials?

This FOA is described as a bridge between preclinical or early clinical concepts and a later, definitive neurology trial, funding critical preparatory clinical work that clarifies whether an intervention is ready for a major trial and how that trial should be designed to produce clear, reliable, and clinically meaningful results.

What are the key dates shown in the record?

The posting date is listed as January 11, 2007, with a creation date of December 5, 2008. The record shows a current closing date of January 7, 2010, and an archive date of February 7, 2010.

Were there multiple receipt dates for applications?

Yes. The announcement operated with multiple receipt dates, and applicants were directed to the full announcement for the specific receipt dates and detailed requirements.

Where can applicants find the full announcement and detailed requirements?

The full announcement is available through the NIH grants guide at http://grants.nih.gov/grants/guide/pa-files/PAR-07-294.html.

Who is listed as the contact for access or linking issues?

For access or linking issues, the contact provided is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Information Technologies and the Internet in Health Services and Intervention Delivery (R01)

Previous opportunity: Advances in Polycystic Kidney Disease (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 07 294

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 07 294) also looked into and applied for these:

Funding Opportunity
Hypersensitivity Pneumonitis Early Identification and Mechanisms of Disease (R01) Apply for PA 07 300

Funding Number: PA 07 300
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mental Health Consequences Of Violence And Trauma (R01) Apply for PA 07 312

Funding Number: PA 07 312
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mental Health Consequences of Violence and Trauma (R03) Apply for PA 07 313

Funding Number: PA 07 313
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Mental Health Consequences Of Violence And Trauma (R34) Apply for PAR 07 315

Funding Number: PAR 07 315
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Mental Health Consequences Of Violence And Trauma (R21) Apply for PA 07 314

Funding Number: PA 07 314
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Stress Management Interventions to Reduce Risk of Coronary Artery Disease (R01) Apply for PA 07 322

Funding Number: PA 07 322
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Hyperglycemic Exacerbation of Ischemia/Reperfusion Injury after Ischemic Insult (R01) Apply for PA 07 323

Funding Number: PA 07 323
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Use Disorders Treatment, Services Research, and Recovery (R03) Apply for PA 07 215

Funding Number: PA 07 215
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot and Feasibility Studies on Oral Health Promotion Research across the Life Span (R21) Apply for PA 07 223

Funding Number: PA 07 223
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Planning Grant for Oral Health Promotion across the Life Span (R21) Apply for PAR 07 224

Funding Number: PAR 07 224
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Oral Health Promotion Research across the Lifespan (R01) Apply for PA 07 225

Funding Number: PA 07 225
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV Treatment Adherence Research (R34) Apply for PAR 07 341

Funding Number: PAR 07 341
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Collaborative Neurological Sciences (CNS) Award (S11) Apply for PAR 07 357

Funding Number: PAR 07 357
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Molecular Mechanisms of Development and Reversal of Alcohol Induced Liver Fibrosis (R01) Apply for PA 07 360

Funding Number: PA 07 360
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Molecular Mechanisms of Development and Reversal of Alcohol Induced Liver Fibrosis (R21) Apply for PA 07 361

Funding Number: PA 07 361
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIBIB Research Revisions to Promote Clinical Resident Research Experiences (Revisions to Currently Active NIBIB R01 and R37 Grants) Apply for PAR 07 363

Funding Number: PAR 07 363
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Grants for Basic Research in Glomerular Diseases (R01) Apply for PA 07 367

Funding Number: PA 07 367
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Simian Models For The Oral Biology Of HIV Infection And AIDS Related Oral Complications (R21) Apply for PA 07 369

Funding Number: PA 07 369
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implicating Noncoding RNAs in the Genetics of Mental Disorders (R01) Apply for PA 07 370

Funding Number: PA 07 370
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implicating Noncoding RNAs in the Genetics of Mental Disorders (Collaborative R01) Apply for PA 07 371

Funding Number: PA 07 371
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 07 294", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.